AZN Shares - AstraZeneca falls 3% as £200m Cambridge expansion put on hold
15-09-2025 02:55
Investing.com -- AstraZeneca (LON:AZN) shares fell 3% on Monday after the drugmaker paused a planned £200 million ($271 million) investment in its Cambridge research hub. The decision, which had been ...
FTSE 100: Can Global Exposure Buffer Against Domestic Economic Hurdles?
The UK has a testing week in prospect as a number of data releases are likely to do little to improve the economic mood. Retail sales and consumer confidence reports will almost certainly show a ...
AstraZeneca's (LON:AZN) investors will be pleased with their notable 61% return over the last five years
The main point of investing for the long term is to make money. But more than that, you probably want to see it ...
Astrazeneca PLC (LON: AZN) - Related Research
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about ...
AstraZeneca shares fall as revenue miss tempers strong Q1 earnings
Investing.com -- AstraZeneca (LON:AZN) (ST:AZN) shares fell more than 3% Tuesday after the drugmaker missed first-quarter revenue expectations, with underperformance in key cancer and respiratory ...
